Wide Ranks

CYTHW

Cyclo Therapeutics, Inc.

0.1400

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 5.10 %
Current Ratio 0.45 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins -4577.99 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.0390 Total Debt 2 M
Total Debt To Equity Current Ratio 0.45 Book Value Per Share 0.1670
All Measures
Message Board Id finmb_3103504 Fax 321 244 8351 City Gainesville
Uuid baf2da6a-6508-3af3-874f-e3179ac5d290 Previous Close 0.0700 First Trade Date Epoch Utc 1 B
Book Value 0.1670 Beta -0.3810 Total Debt 2 M
Volume 540 Price To Book 0.8383 Fifty Two Week Low 0.0500
Total Cash Per Share 0.0390 Total Revenue 1 M Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -4577.99 % Net Income To Common -20738080
Trailing Peg Ratio None Average Daily Volume10 Day 600 Average Volume10days 600
Total Cash 1 M Revenue Per Share 0.0460 Trailing PE 0.0000
Regular Market Previous Close 0.0700 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 0.1566 Open 0.1400 Free Cashflow -10790528
State FL Dividend Yield 0.00 % Return On Assets -2.82
Time Zone Short Name EST Day Low 0.1400 Address1 6714 NW 16th Street
Target High Price 0.0000 Price Hint 4 Website https://cyclotherapeutics.com
52 Week Change -0.4142 Average Volume 945 Recommendation Key none
Forward Eps 0.0000 Compensation As Of Epoch Date 1 B Quick Ratio 12.30 %
Is_sp_500 False Regular Market Day High 0.1400 Profit Margins 0.00 %
Fifty Two Week High 0.3300 Day High 0.1400 Regular Market Open 0.1400
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Revenue Growth 5.10 %
Operating Cashflow -18366346 Currency USD Time Zone Full Name America/New_York
Is_nasdaq_100 False Market Cap 0.0000 Zip 32653
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Long Name Cyclo Therapeutics, Inc.
Regular Market Day Low 0.1400 Current Price 0.1400 Address2 Suite B
Financial Currency USD Current Ratio 0.45 Gross Margins 91.56 %
Industry Disp Drug Manufacturers - Specialty & Generic Country United States Float Shares 15 M
Two Hundred Day Average 0.2064 Forward PE 0.0000 Regular Market Volume 540
Ebitda -21140932 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases.

The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease.

It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019.

Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.